MoneyWorks4Me

Hikal informs about disclosure of related party transactions

19 Nov 2022 Evaluate

Pursuant to the provisions of Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Hikal has informed that it enclosed the disclosure of Related Party Transactions for the half-year ended September 30, 2022. This information is also uploaded on the website of the Company.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..